-
Molnupiravir: COVID drug linked to virus mutations, scientists say | Science & Tech News
admin
A drug used to treat COVID-19 could be linked to mutations in the virus, scientists have said. Molnupiravir works by causing mutations in the virus’s genetic information, or genome, many of which kill or harm the virus, reducing the amount of COVID in the body. Used across the world to treat COVID, it was one…
-
Alzheimer’s: First drug to slow progression of disease gains approval of US regulator the FDA | Science & Tech News
admin
The US Food and Drug Administration (FDA) has fully approved a drug that slows the progression of Alzheimer’s disease for the first time. The FDA has granted full regulatory approval to Leqembi – a drug by Japanese manufacturers Eisai and US drugmakers Biogen. Up to now, other approved drugs targeted only the symptoms of the…
-
New drug can reduce Alzheimer’s disease symptoms by up to 35% | Science & Tech News
admin
A second drug has shown the ability to slow the progression of the leading form of dementia. Results of a study, released in a preliminary form by drug maker Eli Lilly, show their drug donanemab reduced the rate of cognitive decline of Alzheimer’s patients in a trial by between 27 and 35%. Those on the…
-
New long COVID drug may significantly reduce fatigue in patients | UK News
admin
An experimental drug could significantly reduce fatigue in people with long COVID, a new study suggests. Scientists who carried out the small-scale clinical trial believe the drug, called AXA1125, may increase energy production in cells and reduce inflammation for people fighting the virus and its aftereffects. They are calling for larger studies to confirm the…
-
‘Encouraging’ results in trial of psychedelic drug for treating depression | UK News
admin
A psychedelic drug which causes half-an-hour trips has shown some success in treating depression, early trial results suggest. Early evidence from a small trial suggests the powerful pharmaceutical-grade hallucinogenic – known as intravenous DMT, or SPL026 – could improve symptoms of moderate to severe depression when used in conjunction with therapy. According to un-peer reviewed…
-
What is Alzheimer’s disease, how common is it – and will new drug lecanemab help patients in the UK? | UK News
admin
A new drug is making headlines around the world for being the first ever to slow the progression of Alzheimer’s disease. After an 18-month trial of 1,800 patients, lecanemab slowed patients’ mental decline by 27%. Although scientists are hailing a “new era” in treatment, strains on the NHS and the scale and complexity of the…
-
New drug brings hope that decades-long slog to find Alzheimer’s cure might pay off | Science & Tech News
admin
Science is a slog. Not a series of “Eureka!” moments. It’s why I hate the word “breakthrough” when it comes to research discoveries. But in the case of this new drug for Alzheimer’s that word is more than justified. Not because lecanemab is a cure for the disease that is destroying the lives of hundreds…
-
Alzheimers, cure, day, decline, dementia, doctors, drug, fuelling, hope, Lecanemab, memory, News, Science, slows, Tech
Lecanemab: New Alzheimer’s drug slows decline in memory – fuelling hope doctors will one day cure dementia | Science & Tech News
admin
Doctors have hailed a “new era” of medicine after a study showed for the first time that a drug can slow the debilitating symptoms of Alzheimer’s. Results from the clinical trial also revealed that the drug lecanemab cleared clumps of a protein called amyloid – thought to be a key cause of the most common…
-
New drug offers lifeline to 1,600 women with rare aggressive form of breast cancer | UK News
admin
A new drug could benefit hundreds of women suffering from one of the most aggressive forms of breast cancer. Officials have given the NHS the green light to use pembrolizumab to treat 1,600 patients in England suffering from triple negative breast cancer. Typically, the risk of triple negative breast cancer returning and spreading to other…
-
Hope for people with untreatable high blood pressure after trial on new drug Baxdrostat | Science & Tech News
admin
Researchers claim to have found a way to tackle previously untreatable high blood pressure. Scientists from Queen Mary University of London and the US pharmaceutical firm CinCor examined whether patients would benefit from taking a drug called Baxdrostat. Those who took a new medicine during a clinical trial were found to have significantly lower blood…